Involvement of heparin affin regulatory peptide in human prostate cancer

Prostate

Volumn 38, Issue 2, 1999, Pages 126-136

  Vacherot, Francis ^a   Caruelle, Danièle ^a   Chopin, Dominique ^b   Gil Diez, Sixtina ^b   Barritault, Denis ^a   Caruelle, Jean Pierre ^a   Courty, José ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Growth factor; HARP; Prostate; Tumor

Indexed keywords

GROWTH FACTOR; HEPARIN BINDING PROTEIN; MESSENGER RNA; REGULATOR PROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MITOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN LOCALIZATION;

3T3 CELLS; ADENOCARCINOMA; ANIMALS; CARRIER PROTEINS; CYTOKINES; HUMANS; IN SITU HYBRIDIZATION; MALE; MICE; MITOGENS; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RABBITS; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032894996     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19990201)38:2<126::AID-PROS6>3.0.CO;2-C     Document Type: Article

References (54)

1. Brandes D. Prostate gland embryology, anatomy and histology. In: Mill GS, editor. Uropathology. New York: Churchill Livingstone; 1989. p 1165-1180.
2. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ. The endocrinology and the developmental biology of the prostate. Endocr Rev 1987;8:338-363.
3. Bissel MJ, Hall HG, Parry GJ. How does the extracellular matrix direct gene expression? Theor Biol 1982;99:31-68.
4. Streuli CH, Bailey N, Bissel MJ. Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J Cell Biol 1991;115:1383-1395.
5. Cunha GR, Alarid ET, Donjacour AA, Boutin EL, Foster BA. Normal and abnormal development of the male urogenital tract: role of androgens, mesenchymal-epithelial interactions and growth factors. J Androl 1992;13:85-105.
6. Chang SM, Chung LWK. Interactions between prostatic fibroblasts and epithelial cells in culture. Endocrinology 1989;125: 2719-2727.
7. Sakakura T, Nishizuka Y, Dawe CJ. Mesenchymc-dependent morphogenesis and epithelium-specific cytodifferentiation in mouse mammary gland. Science 1976;194:1439-1441.
8. Story MT. Regulation of prostate growth by fibroblast growth factors. World J Urol 1995;13:297-305.
9. Cunha GR, Foster B, Thomson A, Sugimura Y, Tanji N, Tsuji M, Terada N, Finch PW, Donjacour AA. Growth factors as mediators of androgen action during the development of the male urogenital tract. World J Urol 1995;13:264-276.
10. Kadomatsu K, Tomomura M, Muramatsu T. cDNA cloning and sequence of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun 1988;151:1312-1318.
11. Raulais D, Lagente-Chevallier O, Guettet C, Duprez D, Courtois Y, Vigny M. A new heparin binding protein regulated by retinoic acid from chick embryo. Biochem Biophys Res Commun 1991;174:708-715.
12. Merenmies J, Rauvala H. Molecular cloning of the 18-kDa growth associated protein of developing brain. J Biol Chem 1990;265:16721-16724.
13. Li YS, Milner PG, Chauhan AK, Watson MA, Hoffman RM, Kodner CM, Milbrandt J, Deuel TF. Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 1990;250:1690-1694.
14. Tezuka K, Takeshita S, Haneda Y, Kumegawa M, Kikuno R, Hashimoto-Gotoh T. Isolation of mouse and human cDNA clones encoding a protein expressed specifically in osteoblasts and brain tissues. Biochem Biophys Res Commun 1990;173:246-251.
15. Rauvala H. An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factors. EMBO J 1989;8:2933-2941.
16. Laaroubi K, Vacherot F, Delbé J, Caruelle D, Barritault D, Courty J. Biochemical and mitogenic properties of the heparin-binding growth factor HARP. Prog Growth Factor Res 1995;6: 25-34.
17. Courty J, Dauchel MC, Caruelle D, Perderiset M, Barritault D. Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin. Biochem Biophys Res Commun 1991; 180:145-151.
18. Fang W, Hartmann N, Chow DT, Riegel AT, Wellstein A. Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer. J Biol Chem 1992;267: 25889-25897.
19. Delbe J, Vacherot F, Laaroubi K, Barritault D, Courty J. Effect of heparin on bovine epithelial lens cells proliferation induced by heparin affin regulatory peptide. J Cell Physiol 1995;164:47-54.
20. Wellstein A, Fang W, Khatri A, Lu Y, Swain SS, Dickson RB, Sasse J, Riegel AT, Lippman ME. A heparin-binding growth factor secreted from breast cancer cells homologous to a developmentally regulated cytokine. J Biol Chem 1992;267:2582-2587.
21. Laaroubi K, Delbe J, Vacherot F, Desgranges P, Tardieu M, Jaye M, Barritault D, Courty J. Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide. Growth Factors 1994;10:89-98.
22. Chauhan AK, Li YS, Deuel TF. Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice. Proc Natl Acad Sci USA 1993;90:679-682.
23. Choudhuri R, Zhang HT, Donnini S, Ziche M, Bicknell R. An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res 1997;57:1814-1819.
24. Schröder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Maculaso M. The TNM classification of prostate cancer. Prostate 1992;4:129-138.
25. Gleason DF. Histologic grading of prostate cancer. Hum Pathol 1992;23:273-279.
26. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
27. Ledoux D, Caruelle D, Liu J, Crepin M, Barritault D, Courty J. Cellular distribution of the angiogenic factor heparin affin regulatory peptide (HARP) mRNA and protein in the human mammary gland. J Histochem Cytochem 1997;45:1239-1245.
28. Colbere-Garapin F, Horodniceanu F, Kourilsky P, Garapin AC. A new dominant hybrid selective marker for higher eucaryotic cells. J Mol Biol 1981;150:1-14.
29. Vanderwinden JM, Mailleux P, Schiffmann SN, Vanderhaeghen JJ. Cellular distribution of the new growth factor pleiotrophin (HB-GAM) mRNA in developing and adult rat tissues. Anat Embryol (Berl) 1992;186:387-406.
30. Mitsiadis TA, Salmivirta M, Muramatsu T, Muramatsu H, Rauvala H, Lehtonen E, Jalkanen M, Thesleff I. Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin), is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development 1995;121:37-51.
31. Mitsiadis TA, Muramatsu T, Muramatsu H, Thesleff I. Midkine (MK), a heparin-binding growth/differentiation factor, is regulated by retinoic acid and epithelial-mesenchymal interactions in the developing mouse tooth, and affects cell proliferation and morphogenesis. J Cell Biol 1995;129:267-281.
32. Vigny M, Ollier-Hartmann MP, Lavigne M, Fayein N, Jeanny JC, Laurent M, Courtois Y. Specific binding of basic fibroblast growth factor to basement membrane-like structures and to purified heparin sulphate proteoglycan of the EHS tumor. J Cell Physiol 1988;137:321-328.
33. Gitay-Goren H, Soker S, Vlodavsky I, Neufeld G. The binding of vascular endothelial growth factor to its receptor is dependent on cell surface-associated heparin-like molecules. J Biol Chem 1992;267:6093-6098.
34. Chernousov MA, Carey DJ. N-syndecan (syndecan 3) from neonatal rat brain binds basic fibroblast growth factor. J Biol Chem 1993;268:16810-16814.
35. Peng HB, Ali AA, Dai Z, Daggett DF, Raulo E, Rauvala H. The role of heparin-binding growth-associated molecule (HB-GAM) in the postsynaptic induction in cultured muscle cells. J Neuro-sci 1995;15:3027-3038.
36. Raulo E, Chernousov MA, Carey DJ, Nolo R, Rauvala H. Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). J Biol Chem. 1994;269: 12999-13004.
37. Maeda N, Nishiwaki T, Shintani T, Hamanaka H, Noda M. 6B4: proteoglycan/phosphacan, an extracellular variant of receptor-like protein-tyrosine phosphatase ξ/RPTPβ, binds pleiotrophin/heparin-binding growth-associated molecule (HB-GAM). J Biol Chem 1996;271:21446-21452.
38. Milhiet PE, Vacherot F, Caruelle, JP, Barritault D, Caruelle D, Courty J. Upregulation of the angiogenic factor heparin affin regulatory peptide by progesterone in rat uterus. J Endocrinol 1998;158:389-399.
39. Kojima S, Inui T, Kimura T, Sakakibara S, Muramatsu H, Amanuma H, Maruta H, Muramatsu. Synthetic peptides derived from midkine enhance plasminogen activator activity in bovine aortic endothelial cells. Biochem Biophys Res Commun 1995; 206:468-473.
40. Kojima S, Muramatsu H, Amanuma H, Muramatsu T. Midkine enhances fibrinolytic activity of bovine endothelial cells. J Biol Chem 1995;270:9590-9596.
41. Novotny WF, Maffi T, Mehta RL, Milner PC. Identification of novel heparin-releasable proteins, as well as the cytokines midkine and pleiotrophin, in human postheparin plasma. Arterioscler Thromb 1993;13:1798-1805.
42. Kuo MD, Huang SS, Huang JS. Characterization of heparin-binding growth-associated factor receptor on NIH 3T3 cells. Biochem Biophys Res Commun 1992;182:188-194.
43. Story MT, Livingston B, Baeten L, Swartz SJ, Jacobs SC, Begun FP, Lawson RK. Cultured human prostate-derived fibroblasts produce a factor that stimulates their growth with properties indistinguishable from basic fibroblast growth factor. Prostate 1989;15:355-365.
44. Sinowatz F, Amselgruber W, Lincoln D, Sasse J, Kolle S, Plendl J, Kayser K. Role of basic fibroblast growth factor in prostatic tumors. Nutrition 1995;11:619-621.
45. Cronauer MV, Hittmair A, Eder IE, Hobisch A, Culig Z, Ramoner R, Zhang J, Bartsch G, Reissigl A, Radmayr C, Thurnher M, Klocker H. Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate. Prostate 1997;31:223-233.
46. McKeehan WL, Adams PS, Fast D. Different hormonal requirements for androgen-independent growth of normal and tumor epithelial cells from rat prostate. In Vitro Cell Dev Biol 1987;23: 147-152.
47. Ropiquet F, Berthon P, Villette JM, Le Brun G, Maitland NJ, Cussenot O, Fiet J. Constitutive expression of FGF2/bFGF in non-tumorigenic human prostatic epithelial cells results in the acquisition of a partial neoplastic phenotype. Int J Cancer 1997; 72:543-547.
48. Van G, Fukabori Y, Nikolaropoulos S, Wang F, McKeehan WL. Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin. Mol Endocrinol 1992;6:2123-2128.
49. Story MT, Hopp KA, Molter M, Meier DA. Characteristics of FGF-receptors expressed by stromal and epithelial cells cultured from normal and hyperplastic prostates. Growth Factors 1994; 10:269-280.
50. Ittman M, Mansukhani A. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate. J Urol 1997; 157:351-356.
51. Yan G, Fukabori Y, McBride G, Nikolaropolous S, McKeehan WL. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 1993;3:4513-4522.
52. Pisters LL, Troncoso P, Zhau HE, Li W, von Eschenbach AC, Chung LW. c-met proto-oncogene expression in benign and malignant human prostate tissues. J Urol 1995;154:293-298.
53. Humphrey PA, Zhu X, Zarnegar R, Swanson PE, Ratliff TL, Vollmer RT, Day ML. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am J Pathol 1995;147:386-396.
54. Vacherot F, Laaroubi K, Caruelle D, Delbe J, Barritault D, Caruelle JP, Courty J. Upregulation of heparin-affin regulatory peptide by androgen. In Vitro Cell Dev Biol 1995;31:647-648.